La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (enzymology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (economics) < Parkinson Disease (enzymology) < Parkinson Disease (epidemiology)  Facettes :

List of bibliographic references indexed by Parkinson Disease (enzymology)

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
001104 (2012) Benjamin Dehay [France] ; Alfredo Ramirez [Allemagne] ; Marta Martinez-Vicente [Espagne] ; Celine Perier [Espagne] ; Marie-Hélène Canron [France] ; Evelyne Doudnikoff [France] ; Anne Vital [France] ; Miquel Vila [Espagne] ; Christine Klein [Allemagne] ; Erwan Bezard [France]Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
001162 (2012) Annaik Petithomme Feve [France]Current status of tyrosine hydroxylase in management of Parkinson's disease.
001962 (2010) Agnès Petit-Paitel [France][GSK-3beta: a central kinase for neurodegenerative diseases?].
001A18 (2010) Jérémie Vitte [France] ; Sabine Traver ; André Maués De Paula ; Suzanne Lesage ; Giorgio Rovelli ; Olga Corti ; Charles Duyckaerts ; Alexis BriceLeucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease.
002279 (2008) Rene Reese [France] ; Christine Winter ; Agnes Nadjar ; Daniel Harnack ; Rudolf Morgenstern ; Andreas Kupsch ; Erwan Bezard ; Wassilios MeissnerSubthalamic stimulation increases striatal tyrosine hydroxylase phosphorylation.
002B65 (2005) Guylaine Hoffner [France] ; Philippe DjianTransglutaminase and diseases of the central nervous system.
003063 (2003) Benjamin Di Cara [France] ; Denise Samuel ; Pascal Salin ; Lydia Kerkerian-Le Goff ; Annie DaszutaSerotonergic regulation of the GABAergic transmission in the rat basal ganglia.
003126 (2003) Stephane Hunot [France] ; E. C. Hirsch [France]Neuroinflammatory processes in Parkinson's disease
003161 (2003) Clotilde Levecque ; Alexis Elbaz ; Jacqueline Clavel [France] ; Florence Richard ; Jean-Se Bastien Vidal [France] ; Philippe Amouyel ; Christophe Tzourio ; Annick Alpe Rovitch ; Marie-Christine Chartier-HarlinAssociation between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case–control study
003323 (2002) Jean-Jacques Bacci [France] ; Lydia Kerkerian-Le Goff ; Pascal SalinEffects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat.
003812 (2001) C. Levecque [France] ; A. Destee [France] ; V. Mouroux [France] ; E. Becquet [France] ; L. Defebvre [France] ; P. Amouyel [France] ; M.-C. Chartier-Harlin [France]No genetic association of the Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease
003876 (2000) A. Simon [France] ; C. Savy ; E. Martin-Martinelli ; A. Douhou ; F. Frédéric ; C. Verney ; J. Nguyen-Legros ; R. Raisman-VozariParadoxical increase of tyrosine hydroxylase-immunoreactive retinopetal fibers in the weaver mouse.
003886 (2000) Andreas Hartmann [France] ; Stéphane Hunot [France] ; Patrick P. Michel [France] ; Marie-Paule Muriel [France] ; Sheela Vyas [Royaume-Uni] ; Baptiste A. Faucheux [France] ; Annick Mouatt-Prigent [France] ; Hélène Turmel [France] ; Anu Srinivasan [États-Unis] ; Merle Ruberg [France] ; Gerard I. Evan [Royaume-Uni] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
003888 (2000) K. Ancolio [France] ; C. Alves Da Costa ; K. Uéda ; F. CheclerAlpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
003D67 (1999) B. Sanjay Harhangi [Pays-Bas] ; Matthew J. Farrer [États-Unis] ; Sarah Lincoln [États-Unis] ; Vincenzo Bonifati [Italie] ; Giuseppe Meco [Italie] ; Giuseppe De Michele [Italie] ; Alexis Brice [France] ; Alexandra Dürr [France] ; Maria Martinez [France] ; Thomas Gasser [Allemagne] ; Benjamin Bereznai [Allemagne] ; Jenny R. Vaughan [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [États-Unis] ; Ben A. Oostra [Pays-Bas] ; Monique M. B. Breteler [Pays-Bas]The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease
004205 (1997) M. Vila [France] ; R. Levy ; M T Herrero ; M. Ruberg ; B. Faucheux ; J A Obeso ; Yves Agid [France] ; E C HirschConsequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
004483 (1996) R. Bordet [France] ; F. Broly ; A. Destée ; C. LibersaDebrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
004579 (1996) S. Hunot [France] ; F. Boissière [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France]Nitric oxide synthase and neuronal vulnerability in parkinson's disease
004583 (1996) G. Lucotte [France] ; J. Turpin [France] ; N. Gérard [France] ; S. Panserat [France] ; R. Krishnamoorthy [France]Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families
004586 (1996) M. Vila [France] ; R. Levy [France] ; M.-T. Herrero [Espagne] ; B. Faucheux [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France]Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study
004671 (1996) P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France]Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (enzymology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (enzymology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (enzymology)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024